The diagnosis and management of uveitis
- PMID: 7729329
- DOI: 10.2165/00003495-199549020-00006
The diagnosis and management of uveitis
Abstract
The diagnosis and management of uveitis is complicated and challenging. The protean signs and symptoms seen in patients with uveitis may lead to a diagnostic dilemma. A carefully taken history with particular attention to demographic factors and meticulous physical examination are crucial to guiding diagnostic testing. Tailoring the diagnostic approach in patients with uveitis frequently yields useful data in contrast to blanketing every possible uveitic entity. It is also important to distinguish among various aetiologies, including infectious and neoplastic causes which may respond to specific therapy. Medical treatment of noninfectious uveitis must have clear objectives including reduction of inflammation, relief of symptoms and restoration of visual functioning. Familiarity with possible symptoms and signs of adverse drug reactions is essential early in the course of treatment so that their effects may be minimised. Appropriate therapy of presumed autoimmune uveitis is based on disease severity, presence or absence of bilateral disease and the health status of the patient.
Similar articles
-
[Medical treatment of severe uveitis].Ophtalmologie. 1989 Jan-Mar;3(1):37-9. Ophtalmologie. 1989. PMID: 2641067 French.
-
Use of steroids and immunosuppressive drugs in the management of posterior uveitis.Eye (Lond). 1991;5 ( Pt 3):294-8. doi: 10.1038/eye.1991.46. Eye (Lond). 1991. PMID: 1955050
-
Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.Semin Respir Crit Care Med. 2011 Jun;32(3):346-70. doi: 10.1055/s-0031-1279831. Epub 2011 Jun 14. Semin Respir Crit Care Med. 2011. PMID: 21674420 Review.
-
Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.Inflamm Bowel Dis. 2005 Feb;11(2):197-9. doi: 10.1097/00054725-200502000-00014. Inflamm Bowel Dis. 2005. PMID: 15677914 No abstract available.
-
Uveitis for the non-ophthalmologist.BMJ. 2021 Feb 3;372:m4979. doi: 10.1136/bmj.m4979. BMJ. 2021. PMID: 33536186 Review.
Cited by
-
Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population.Ophthalmol Ther. 2015 Jun;4(1):1-19. doi: 10.1007/s40123-014-0027-6. Epub 2014 Dec 12. Ophthalmol Ther. 2015. PMID: 25502122 Free PMC article.
-
Management of uveitis in pediatric patients: special considerations.Paediatr Drugs. 2002;4(3):183-9. doi: 10.2165/00128072-200204030-00005. Paediatr Drugs. 2002. PMID: 11909010 Review.
-
Magnetically Assisted Drug Delivery of Topical Eye Drops Maintains Retinal Function In Vivo in Mice.Pharmaceutics. 2021 Oct 9;13(10):1650. doi: 10.3390/pharmaceutics13101650. Pharmaceutics. 2021. PMID: 34683941 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical